Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC49H59N11O12 |
InChIKeyWIBYSQOAEHEXJZ-UHFFFAOYSA-N |
CAS Registry- |